Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,300
-50 (-0.19%)
Jun 4, 2026, 2:25 PM KST
Market Cap154.94B -2.6%
Revenue (ttm)211.44B +3.1%
Net Income26.98B -18.6%
EPSn/a
Shares Out 5.88M
PE Ratio5.74
Forward PE4.71
Dividend900.00 (3.42%)
Ex-Dividend DateDec 29, 2025
Volume8,064
Open26,350
Previous Close26,350
Day's Range26,150 - 26,550
52-Week Range25,850 - 33,950
Beta0.16
Analystsn/a
Price Targetn/a
Earnings DateMay 29, 2026

About Daihan Pharmaceutical

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2025, Daihan Pharmaceutical's revenue was 208.61 billion, an increase of 2.16% compared to the previous year's 204.19 billion. Earnings were 27.64 billion, a decrease of -18.11%.

Financial Statements